158 related articles for article (PubMed ID: 1983342)
1. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.
Koop H; Hotz J; Pommer G; Klein M; Arnold R
Aliment Pharmacol Ther; 1990 Dec; 4(6):593-9. PubMed ID: 1983342
[TBL] [Abstract][Full Text] [Related]
2. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
[TBL] [Abstract][Full Text] [Related]
4. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
Koop H; Katschinski M; Arnold R
Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
[TBL] [Abstract][Full Text] [Related]
7. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
Koop H; Arnold R
Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
[TBL] [Abstract][Full Text] [Related]
8. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1989; 44 Suppl 1():47-53. PubMed ID: 2575061
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
Klinkenberg-Knol EC; Meuwissen SG
Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
[TBL] [Abstract][Full Text] [Related]
11. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG
Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
McTavish D; Buckley MM; Heel RC
Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
[TBL] [Abstract][Full Text] [Related]
13. Experience with omeprazole in erosive oesophagitis.
Robinson MG; Decktor DL
Aliment Pharmacol Ther; 1991; 5 Suppl 1():69-77. PubMed ID: 1679674
[TBL] [Abstract][Full Text] [Related]
14. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological management of gastro-oesophageal reflux disease.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
[TBL] [Abstract][Full Text] [Related]
17. The use of omeprazole for resistant oesophagitis in children.
Martin PB; Imong SM; Krischer J; Noblett HR; Sandhu BK
Eur J Pediatr Surg; 1996 Aug; 6(4):195-7. PubMed ID: 8877348
[TBL] [Abstract][Full Text] [Related]
18. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
[TBL] [Abstract][Full Text] [Related]
19. The clinical utility and safety of omeprazole.
Walan A
Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
[TBL] [Abstract][Full Text] [Related]
20. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
